Estimation of time-dependent rate ratios in case-control studies: Comparison of two approaches for exposure assessment

Pharmacoepidemiology and Drug Safety

Volumn 15, Issue 5, 2006, Pages 304-316

  Lefebvre, Geneviève ^a   Angers, Jean Francçois ^a   Blais, Lucie ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Assessment of exposure; Case control study; Duration of exposure; Time since the end of exposure; Time dependent rate ratios; Time window

Indexed keywords

ARTICLE; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; DRUG EXPOSURE; DRUG WITHDRAWAL; INTERMETHOD COMPARISON; PHARMACOEPIDEMIOLOGY; POISSON DISTRIBUTION; PRIORITY JOURNAL; REGRESSION ANALYSIS; RISK ASSESSMENT; SIMULATION; THEORETICAL SAMPLE; TIME;

CASE-CONTROL STUDIES; HUMANS; PHARMACOEPIDEMIOLOGY; TIME FACTORS;

EID: 33744462587     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1201     Document Type: Article

References (28)

1. Albanes D, Schatzkin A, Micozzi MS. Time-related factors in research on diet and cancer. J Chronic Dis 1987; 40 (Suppl. 2): 39S-44S.
2. Rosenberg L, Palmer JR, Rao RS, et al. Case-control study of oral contraceptive use and risk of breast cancer. Am J Epidemiol 1996; 143: 25-37.
3. Hayes RB, Yin SN, Dosemeci M, et al. Benzene and the dose-related incidence of hematologic neoplasm in China. J Natl Cancer Inst 1997; 89: 1065-1071.
4. Brooks DR, Palmer JR, Strom BL, et al. Menthol cigarettes and risk of lung cancer. Am J Epidemiol 2003; 158: 609-616.
5. Beral V, Million Women Study Collaborators. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 2003; 362: 419-427.
6. Gonzalez CA, Pera G, Agudo A, et al. Smoking and the risk of gastric cancer in the european prospective investigation into cancer and nutrition (EPIC). Int J Cancer 2003; 107: 629-634.
7. Terry P, Ekbom A, Lichtenstein P, et al. Long-term tobacco smoking and colorectal cancer in a prospective cohort study. Int J Cancer 2001; 95: 585-587.
8. Blais L, Ernst P, Boivin JF, et al. Inhaled corticosteroids and the prevention of readmission to hospital for asthma. Am J Respir Crit Care Med 1998; 158: 126-132.
9. Moride Y, Abenhaim L. Evidence of the depletion of susceptibles effect in non-experimental pharmacoepidemiologic research. J Clin Epidemiol 1994; 47: 731-737.
10. Traversa G, Walker AM, Ippolito FM, et al. Gastroduodenal toxicity of different nonsteroidal antiinflammatory drugs. Epidemiology 1994; 6: 49-54.
11. Spitzer WO, Lewis MA, Heinemann Lothar AJ, et al. Transnational research group on oral contraceptives and the health of young women. Third generation oral contraceptives and risk of venous thromboembolic disorders: An international case-control study. BMJ 1996; 312: 83-88.
12. Evans JMM, McMahon AD, Murray FE, et al. Non-steroidal anti-inflammatory drugs are associated with emergency admission to hospital for colitis due to inflammatory bowel disease. Gut 1997; 40: 619-622.
13. Suissa S, Assimes T, Ernst P. Inhaled short acting β agonist use in COPD and the risk of acute myocardial infarction. Thorax 2003; 58: 43-46.
14. Gutthann SP, Garcia Rodriguez LA, Raiford DS, et al. Nonsteroidal anti-inflammatory drugs and the risk of hospitatization for acute renal failure. Arch Intern Med 1996; 156: 2433-2439.
15. Zornberg GL, Jick H. Antipsychotic drug use and risk of first-time idiopathic venous thromboembolism: A case-control study. Lancet 2000; 356: 1219-1223.
16. Bak S, Andersen M, Tsiropoulos I, et al. Risk of stroke associated with nonsteroidal anti-inflammatory drugs: A nested case-control study. Stroke 2003; 34: 379-386.
17. Miettinen OS, Caro JJ. Principles of nonexperimental assessment of excess risk, with special reference to adverse drug reactions. J Clin Epidemiol 1989; 42: 325-331.
18. Blais L, Desgagné A, LeLorier J. 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors and the risk of cancer. Arch Intern Med 2001; 160: 2363-2368.
19. Rosenberg L, Palmer JR, Shapiro S. A case-control study of myocardial infarction in relation to use of estrogen supplements. Am J Epidemiol 1993; 137: 54-63.
20. Blais L, Suissa S, Boivin JF. First treatment with inhaled corticosteroids and the prevention of admissions to hospital for asthma. Thorax 1998; 53: 1025-1029.
21. Anonymous. Venous thromboembolic disease and combined oral contraceptives: Results of International Multicentre Case-Control Study. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Lancet 1995; 346: 1575-1582.
22. Li CI, Malone KE, Porter PL, et al. Relationship between long durations and different regimens of hormone therapy and risk of breast cancer. JAMA 2003; 289: 3304-3306.
23. Li R, Gi]liland FD, Baumgartner K, et al. Hormone replacement therapy and breast carcinoma risk in Hispanic and non-Hispanic women. Cancer 2002; 95: 960-968.
24. Blais L. Observational Studies of Drug Effectiveness in Asthma: Time-related Issues. Doctoral thesis: Mc Gill University, 1997.
25. Guess HA. Behavior of the exposure odds ratio in a case-control study when the hazard function is not constant over time. J Clin Epidemiol 1989; 42: 1179-1184.
26. Rothman KJ, Greenland S. Case-Control Studies. In Modern Epidemiology, 2nd edn, Rothman KJ, Greenland S. (eds). Lippincott Williams & Wilkins: Philadelphia, PA, 1998; 93-113.
27. Hosmer DW, Lemeshow S. Applied Logistic Regression. John Wiley & Sons: New York, NY, 1989.
28. Lubin JH, Gail MH. Biased selection of controls for case-control analyses of cohort studies. Biometrics 1984; 40: 63-75.